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Objective To determine the frequency of depression in Parkinson’s disease (PD) in routine clinical care, and to examine its
association with co-morbid psychiatric and medical conditions and healthcare utilization.
Methods Depression diagnoses and healthcare utilization data for all male veterans with PD age 55 or older seen in fiscal
year 2002 (n¼ 41,162) were analyzed using Department of Veterans Affairs (VA) national databases. Frequencies of
co-morbid disorders and healthcare utilization were determined for depressed and non-depressed patients; associations with
depression were examined using multivariate logistic regression models.
Results A depression diagnosis was recorded for 18.5% of PD patients, including major depression in 3.9%. Depression
decreased in frequency and severity with increasing age. In multivariate logistic regression models, depressed patients had
significantly greater psychiatric and medical co-morbidity, including dementia, psychosis, stroke, congestive heart failure,
diabetes, and chronic obstructive pulmonary disease than non-depressed patients (all p< 0.01). Depressed PD patients were
also significantly more likely to have medical (OR¼ 1.34, 95% CI¼ 1.25–1.44) and psychiatric hospitalizations (OR¼ 2.14,
95% CI¼ 1.83–2.51), and had more outpatient visits (p< 0.01), than non-depressed PD patients in adjusted models.
Conclusion Depression in PD in non-tertiary care settings may not be as common or as severe as that seen in specialty care,
though these findings also may reflect under-recognition or diagnostic imprecision. The occurrence of depression in PD is
associated with greater psychiatric and medical co-morbidity, and greater healthcare utilization. These findings suggest that
screening for depression in PD is important and should be embedded in a comprehensive psychiatric, neuropsychological,
and medical evaluation. Copyright # 2006 John Wiley & Sons, Ltd.key words— depression; Parkinson’s disease; frequency; co-morbidity; healthcare utilizationINTRODUCTION
Parkinson’s disease (PD) is the second most common
neurodegenerative disorder, after Alzheimer’s disease,*Correspondence to: Dr P. Chen, Cleveland VA Medical Center,
Psychiatry Service 116A (B), 10000 Brecksville Road, Brecksville,
Oh 44141, USA. E-mail: Peijun.chen@med.va.gov
Copyright # 2006 John Wiley & Sons, Ltd.affecting approximately one million persons in the
United States (Tandberg et al., 1996; de Rijk et al.,
1997). Depression is common in PD (Cummings,
1992; Slaughter et al., 2001) and is associated with
more rapid decline in activities of daily living
(Starkstein et al., 1992), cognitive decline (Marder
et al., 1995), reduced quality of life (Kuopio et al.,
2000), excess disability (Weintraub et al., 2004), and
mortality (Hughes et al., 2004).Received 26 January 2006
Accepted 26 July 2006
544 p. chen ET AL.Widely varying rates of depression in PD patients
have been reported. Slaughter et al. (2001) summar-
ized 44 studies finding that depression rates ranged
from 7–70%. Differences in classification, diagnostic
tools, demographic characteristics, sample size and
severity of PD may contribute to the variation in
depression rates. Another important factor is study
setting; community-based studies (Hantz et al., 1994;
Tandberg et al., 1996; Schrag et al., 2001) have
reported lower rates of major depression (3–8%) and
depression overall (20–24%) than studies involving
patients treated in tertiary care settings. In the latter,
rates of major depression ranged from 21–40%
and depression overall ranged from 41–54% (Sano
et al., 1989; Dooneief et al., 1992; Hoogendijk et al.,
1998; Starkstein et al., 1998; Lemke et al., 2005).
However, the frequency and types of depression
in PD patients receiving routine clinical care are
not known.
Regarding co-morbid disorders, both psychosis and
cognitive impairment are common in PD (Ismail and
Richard, 2004; Aarsland et al., 2005), and studies
suggest that there may be increased rates of these
symptoms in PD patients with depression (Marder
et al., 1995; Kuzis et al., 1997; Marsh et al., 2004).
Although an association between depression and
many chronic medical conditions in general has been
reported (Evans and Charney, 2003), it is not clear if
PD patients with depression have excess medical or
neurological co-morbidity compared with non-
depressed PD patients.
The goals of this study were to report the freque-
ncy of depression diagnosed in a large national
sample of PD patients receiving routine clinical
care, and to examine co-morbid psychiatric and
medical conditions and healthcare utilization in this
population.
METHODS
Data from fiscal year 2002 were derived from
Department of Veterans Affairs (VA) national data-
bases. Subjects with PD were identified using the
following codes of International Classification of
Diseases 9th Revision, Clinical Modification
(ICD9CM, WHO, 1994): idiopathic PD (332.0), other
degenerative diseases of the basal ganglia (333.0), and
unspecified extrapyramidal disease (333.90). The
latter two diagnostic codes were included given
diagnostic imprecision that can occur in non-specialty
clinics; thus, inclusive rather than exclusive criteria
were applied.Copyright # 2006 John Wiley & Sons, Ltd.As in other studies examining depression in
non-psychiatric settings (Unutzer et al., 2002;
Valenstein et al., 2004; Alexopoulos et al., 2005),
subjects with depression were identified using
ICD9CM codes for depressive disorders (296.2x,
296.3x, 296.90, 296.99, 300.4, 311, 293.83, 301.12,
309.0 or 309.1) in order to: (1) capture clinically
significant depressive symptoms; (2) acknowledge the
diagnostic imprecision commonly seen in primary
care settings with regard to depression diagnoses; and
(3) account for variability in the clinical presentation
of depression in PD (Ehrt et al., 2006).
There were a total of 43,772 subjects with a
diagnosis of PD as defined above, the overwhelming
majority of whom were male (n¼ 43,104 [98.5%]),
and age 55 or above (n¼ 41,162 [94%]). Therefore,
only male PD patients age 55 or older (7,599 with
depression, 33,563 without depression) were included
in our primary analyses. An additional group of male
depressed patients age 55 or older without PD
(n¼ 247,681) was identified from the same databases
and used in our secondary analyses.
Chi-square tests were used to analyze differences
for categorical variables and Student’s t-tests for
continuous variables at the 99% significance level (to
accommodate for the potential for type I error given
the large sample size in this study). Multivariate
regression models adjusting for age, marital status and
race were used to evaluate possible associations
between depression and commonly reported
co-morbid conditions (psychosis, dementia, cerebro-
vascular accidents [CVA], congestive heart failure
[CHF], diabetes, and chronic obstructive pulmonary
disease [COPD]), and between depression and
healthcare utilization. Point estimates (odd ratios)
and 95% confidence intervals (95% CIs) were
reported. All analyses were performed with SAS
statistical software.
RESULTS
Demographic characteristics and frequency of
depression
The overall frequency of depression in PD was 18.5%.
The frequency of depression decreased with increas-
ing age (Table 1). PD patients with depression were
younger, more likely to be Caucasian, and less likely
to be married than PD patients without depression.
Types of depression in PD by age group
Major depression accounted for approximately 21.3%
of depression cases among PD patients, whileInt J Geriatr Psychiatry 2007; 22: 543–548.
DOI: 10.1002/gps
Table 1. Characteristics of patients with Parkinson’s disease, male, age 55 or over by depression diagnosis
Characteristic PD patients with Depression (n¼ 7,599) PD patients without Depression (n¼ 33,563) p-value
Age group <0.0001
55–64 (n¼ 3755) 944 (12.4%) 2811 (8.4%)
65–74 (n¼ 14056) 2536 (33.4%) 11520 (34.3%)
75þ (n¼ 23351) 4119 (54.2%) 19232 (57.3%)
Ethnic group <0.0001
Caucasian (n¼ 22868) 4825 (63.5%) 18043 (53.8%)
Non-Caucasian (n¼ 18294) 2774 (36.5%) 15520 (46.2%)
Marital status <0.01
Married (n¼ 30877) 5583 (73.5%) 25294 (75.4%)
Not-married (n¼ 10285) 2016 (26.5%) 8269 (24.6%)
depression in parkinson’s disease 545non-major depressive episodes (labeled as minor
depression) accounted for the other 78.7% of cases.
The frequency of major depression was higher in
patients ages 55–64 (n¼ 308; 8.2% of entire
population age 55–64), than in those 65–74 years
old (n¼ 545; 3.9%; p< 0.001), or those age 75 and
above (n¼ 767; 3.3%; p< 0.001). The ratio of minor
to major depression increased from approximately 2.1
in the 55–64 year-old age group to 3.7 in 65–74
year-old group to 4.4 in those age 75 and above
(p< 0.001).
Co-morbid disorders in PD by depression
diagnosis
Compared with non-depressed PD patients, those with
concurrent depression had significantly higher rates of
dementia, psychosis, CVA, CHF, diabetes, and COPD
(all p-values <0.01) (Table 2). In the adjusted models,
each comorbid condition was significantly associated
with presence of depression.
Healthcare utilization in PD by depression
diagnosis
Significantly more PD patients with depression had
medical and psychiatric hospitalizations over aTable 2. Medical and psychiatric comorbidities by depression diagn




Dementia 1578 (20.8%) 4109
Psychosis 1059 (13.9%) 3370
CVA 1095 (14.4%) 3095
CHF 792 (10.4%) 2582
Diabetes 1758 (23.3%) 6797
COPD 1072 (14.1%) 3185
*Logistic regression models of association between depression and eac
CVA¼Cerebrovascular accidents; CHF¼Congestive heart failure; C
Copyright # 2006 John Wiley & Sons, Ltd.12-month period than non-depressed PD patients
(Table 3). Results from multivariable logistic
regression models (Table 4) showed that depression
was independently associated with both psychiatric
and medical hospitalizations. In addition, depressed
PD patients also had significantly more medical,
psychiatric, and total outpatient visits than non-
depressed PD patients in both univariate and multi-
variate analyses.
Secondary analyses
To further investigate whether higher comorbidity was
related to depression itself or the combination of PD
and depression, we compared the PD patients with
depression to a group of older depressed patients
without PD. In these analyses, we found that PD
patients with depression had a significantly higher
frequency of dementia (20.8% vs 5.4%, p< 0.001),
psychosis (13.9% vs 6.3%, p< 0.001), and CVA
(14.4% vs 8.6%, p< 0.001) compared with depressed
patients without PD. There were no significant
differences in rates of CHF (10.4% vs 8.9%
p¼ 0.40), and depressed patients without PD had
significantly higher rates of diabetes (27.4% vs 23.3%,
p< 0.0001) and COPD (18.1% vs 14.1%, p< 0.001)





(12.2%) <0.0001 1.78 (1.67, 1.91)
(10.0%) <0.0001 1.11 (1.03, 1.20)
(9.2%) <0.0001 1.42 (1.31, 1.53)
(7.7%) <0.0001 1.24 (1.14, 1.35)
(20.3%) 0.0088 1.09 (1.02, 1.15)
(9.5%) <0.0001 1.36 (1.26, 1.47)
h comorbid condition after adjusting for age, race and marital status.
OPD¼Chronic obstructive pulmonary disease.
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Table 3. Hospital utilization by depression diagnosis
Type of Care* PD patients with depression
(n¼ 7599)




No. of patients, n (%) 2,165 (28.5%) 5,634 (16.8%) X2¼ 552.71, p< 0.0001
No. of admissions, mean (SD) 2.0 (1.5) 1.8 (1.3) t¼6.35, p< 0.0001
Psychiatric admissions
No. of patients, n (%) 318 (4.2%) 551 (1.6%) X2¼ 193.90, p< 0.0001
No. of admissions, mean (SD) 1.5 (1.1) 1.5 (1.0) t¼ 0.42, p¼ 0.6715
Medical admissions
No. of patients, n (%) 1,588 (20.9%) 4,293 (12.8%) X2¼ 332.51, p< 0.0001
No. of stays, mean (SD) 1.7 (1.2) 1.6 (1.0) t¼4.68, p< 0.0001
Other institutional care**
No. of patients, n (%) 915 (12.0%) 2,156 (6.4%) X2¼ 283.18, p< 0.0001
No of admissions, mean (SD) 1.3 (0.7) 1.2 (0.6) t¼3.22, p¼ 0.0013
Outpatient care
No. of patients, n (%) 7,483 (98.5%) 33024 (98.4%) X2¼ 0.25,p¼ 0.6174
No. of visits, mean (SD) 27.0 (35.5) 15.9 (22.7) t¼25.62, p< 0.0001***
Psychiatric visits
No. of patients, n (%) 3819 (50.2%) 3,878 (11.6%) X2¼ 6104.82, p< 0.0001
No. of visits, mean (SD) 7.6 (22.5) 9.5 (29.9) t¼ 3.17, p< 0.01***
Medical visits
No. of patients, n (%) 7,468 (98.3%) 32,995 (98.3%) X2¼ 0.037, p¼ 0.8475
No. of visits, mean (SD) 23.1 (28.4) 14.8 (18.7) t¼24.16, p< 0.0001***
*Care received over 12-month period in fiscal year of 2002.
**Other institutional inpatient care includes residential rehabilitation, domiciliary and vocational care, and nursing home care.
***All p-values <0.01 after adjusting for age, race, marital status, and comorbid conditions in linear regression models (log-transformed) for
association between depression and number of outpatient visits.
546 p. chen ET AL.As prevalence rates of depression are higher in
women in general, and our main study sample
included only men, we performed additional analyses
to investigate the impact of sex on diagnostic rates.
Including male and female patients with PD
(n¼ 43,772), rates of depression were higher in
women than men in all age groups (age 55 and below:
42.2% vs 30.8%; age 55–64: 41.2% vs 25.0%; age
65–74: 25.3% vs 18.0%; age 75 and older: 22.1% vs
17.6%); however, gender differences diminished with
increasing age. As only a small fraction of PD patients
in the main study sample were aged 55 and below
(4.7%) and aged 55–64 (8.7%), we suspected that the
greater gender difference seen in younger-old patients
should have less impact on our estimate of overall
depression frequency in PD patients. Consistent with
this, we found that the weighted (i.e. assuming a
population with an equal number of male and female
subjects) overall prevalence of depression in PD
subjects age 55 or above was 21.7%.
DISCUSSION
We found that depression was common in a national
sample of older male veterans with PD, with a
diagnosis of depression recorded in approximatelyCopyright # 2006 John Wiley & Sons, Ltd.19% of patients. Other findings included a decrease in
frequency and severity of depression with increasing
age. Depressed compared with non-depressed PD
patients had significantly greater psychiatric and
medical co-morbidity, including dementia, psychosis,
stroke, congestive heart failure, diabetes, and chronic
obstructive pulmonary disease. Depressed PD patients
were also significantly more likely to have medical
and psychiatric hospitalizations, and had more out-
patient visits than non-depressed PD patients.
Most depression cases were recorded as episodes of
non-major depression. While this may represent
diagnostic non-specificity in non-psychiatric settings,
these findings are consistent with recent epidemiolo-
gical literature that minor forms of depression are far
more common than major depression in PD. A
community-based study of 245 subjects with PD
revealed major depression in 7.7% and minor
depression in 45.3% of patients (Tandberg et al.,
1996). A multi-site study of 657 PD patients found
minor depression was twice as common as moderate
to severe depression, as measured with a depression
rating scale (Lemke et al., 2005). Overall, it is
estimated that major depression may occur in 5–10%
of PD patients, with an additional 10–30% experien-
cing depression of milder severity (Weintraub, 2004).Int J Geriatr Psychiatry 2007; 22: 543–548.
DOI: 10.1002/gps
Table 4. Predictors of hospitalization for Parkinson’s disease
patients*
Independent variables Odds Ratio
(95% CI)
p
Model 1: all cause of hospitalization
Depression 1.50 (1.40–1.60) <0.0001
Psychosis 2.99 (2.88–3.36) <0.0001
Dementia 4.19 (3.91–4.50) <0.0001
CVA 2.97 (2.75–3.22) <0.0001
CHF 3.11 (2.85–3.39) <0.0001
Diabetes 1.49 (1.40–1.60) <0.0001
COPD 2.61 (2.41–2.82) <0.0001
Model 2: medical hospitalization
Depression 1.34 (1.25–1.44) <0.0001
Psychosis 1.75 (1.61–1.90) <0.0001
Dementia 2.87 (2.66–3.09) <0.0001
CVA 2.76 (2.54–2.99) <0.0001
CHF 3.38 (3.10–3.69) <0.0001
Diabetes 1.63 (1.52–1.74) <0.0001
COPD 2.61 (2.41–2.83) <0.0001
Model 3: psychiatric hospitalization
Depression 2.14 (1.83–2.51) <0.0001
Psychosis 18.53 (15.64–21.95)<0.0001
Dementia 3.06 (2.59–3.61) <0.0001
CVA 1.37 (1.12–1.67) 0.0018
CHF 0.86 (1.67–1.12) 0.2631
Diabetes 1.18 (0.997–1.40) 0.0543
COPD 1.65 (1.37–1.98) <0.0001
CVA¼Cerebrovascular accidents; CHF¼Congestive heart failure;
COPD¼Chronic obstructive pulmonary disease.
*Multivariate logistic regression models adjusted for age, race,
marital status.
depression in parkinson’s disease 547We also found that with increasing age, major
depression significantly decreased and minor depres-
sion increased. These findings are consistent with
those from the general population (Katz et al., 2005),
and may reflect possible attenuation in depression
severity with increasing age, both in general and in PD
patients.
Other findings included the association between
depression in PD and greater psychiatric and medical
co-morbidity. In secondary analyses comparing
patients with PD and depression to depressed patients
without PD, we found that while the combination of
PD and depression was significantly associated with
certain comorbidities (dementia, psychosis, and
CVA), it was not associated with others (CHF,
diabetes, COPD). The findings support the well-
reported association between depression and both
psychiatric and medical comorbidity (Geerlings et al.,
2000), with possible PD-specific additive or protective
effects.
While it is not surprising that psychosis, dementia
and depression were major predictors of psychiatricCopyright # 2006 John Wiley & Sons, Ltd.hospitalizations, and CHF, CVA, COPD, and dementia
were major predictors of medical hospitalizations, our
findings demonstrate that depression is an independent
predictor of both psychiatric and medical hospitaliz-
ations in PD. Depression, either through biological or
psychological mechanisms, may lead to greater
severity of medical co-morbidity and/or to increased
healthcare-seeking behavior.
Our results should be interpreted with caution,
given that all patients studied were male veterans age
55 or older. This may have led to an underestimation
of the overall prevalence rate of depression in PD, so
the findings cannot be generalized to nonveterans,
females, or younger PD patients. It is also possible
that depression was under-recognized in our sample
of patients receiving routine clinical care. If so, it
may have resulted in part from: (1) diagnosis-related
issues such as symptom overlap between PD and
depression; (2) atypical features of depression in
some patients (Ehrt et al., 2006); (3) patient-related
issues such as poor recognition or reporting of
symptoms; or (4) delivery of care-related factors
such as limited time to assess depression or low rates
of depression screening in primary care and
neurology clinics (Shulman et al., 2002; Weintraub
et al., 2003). However, the relatively lower
frequency of depression found in our study is
consistent with recent research that depression in PD
is not as common in patients seen in non-tertiary care
settings (Tandberg et al., 1996). Other limitations
include the retrospective nature of study and the use
of administrative databases, which did not allow us
to assess the accuracy of psychiatric, neurological,
or medical diagnoses.
In conclusion, these findings suggest that depres-
sion in PD is common in routine clinical care settings,
though not as common or as severe as seen in tertiary
care settings, and is associated with both greater
psychiatric and medical co-morbidity and with
increased healthcare utilization. They highlight the
importance of screening for depression and
co-morbidities in this population. They also provide
further evidence in support of recently published
clinical guidelines developed by the American
Academy of Neurology and quality of care indicators
developed by the VA Parkinson’s Disease Research,
Education, and Clinical Centers (PADRECC’s) that
endorse a comprehensive psychiatric, neuropsycho-
logical, and medical evaluation (Cheng et al., 2004;
Miyasaki et al., 2006). In addition, future health
services studies should address ways to better
coordinate care for PD patients that is delivered in
mental health, primary care, and neurology settings.Int J Geriatr Psychiatry 2007; 22: 543–548.
DOI: 10.1002/gps
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